Benzinga | Oct 19, 2021 03:39PM EDT

Venus Concept's Pain Management Device Scores FDA Nod

* The FDA has given 510(k) clearance to Venus Concept Inc's (NASDAQ:VERO) Venus Freedom device for pain management.

* Venus Freedom is a noninvasive, non-ablative device with three applicators to deliver non-thermal radiofrequency energy combined with massage and magnetic field pulses.

* It is intended for minor muscle aches & pain, relief of muscle spasms, and temporary improvement of local blood circulation.

* Related: Venus Concept Stock Trades Higher After Lifting FY21 Sales Outlook.

* The Company will commence a limited launch of Venus Freedom in the U.S. during Q1 of 2022.

* Price Action: VERO shares are up 2.50% at $2.05 during the market session on the last check Tuesday.